Vevye

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Dry EyeMeibomian Gland Dysfunction

10 competitors in Dry Eye

#DrugCompanyPhaseTrials

1

Neoral

Novartis

Phase 3

12

HUMULIN R

BBaxter Healthcare Corporation

Approved

13

Vevye

Roche

Phase 3

14

Accutane

CConrado Roberto Hoffmann Filho

Preclinical

15

Diquafosol Tetrasodium

Merck & Co.

Preclinical

16

SYSTANE ULTRA Lubricant Eye

AAlcon Research

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Dry Eye1 trial

Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 Weeks

Not yet recruiting·—·Phase 4·NCT07368595·60 enrolled

Meibomian Gland Dysfunction1 trial

Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction

Not yet recruiting·UUniversity of Alabama at Birmingham·Phase 4·NCT07224529·48 enrolled

Dry Eye Disease1 trial

A Longitudinal, Open-label, Multi-center Study to Explore the Relationship Between Signs, Symptoms, Molecular and Imaging Biomarkers in Participants With Dry Eye Disease Following Anti-inflammatory Treatment

Completed·Roche·Approved·NCT07025811·378 enrolled

Details

Drug Info

Related News